CN102018847A - Chinese medicinal preparation for treating dysmenorrhea and postpartum blood stasis - Google Patents
Chinese medicinal preparation for treating dysmenorrhea and postpartum blood stasis Download PDFInfo
- Publication number
- CN102018847A CN102018847A CN2009101695153A CN200910169515A CN102018847A CN 102018847 A CN102018847 A CN 102018847A CN 2009101695153 A CN2009101695153 A CN 2009101695153A CN 200910169515 A CN200910169515 A CN 200910169515A CN 102018847 A CN102018847 A CN 102018847A
- Authority
- CN
- China
- Prior art keywords
- parts
- preparation
- blood stasis
- dysmenorrhea
- chinese medicinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicinal preparation for treating dysmenorrhea and postpartum blood stasis. The Chinese medicinal preparation comprises the following raw material medicaments in part by weight: 15 parts of motherwort herb, 15 parts of Chinese angelica, 10 parts of nutgrass galingale rhizome, 10 parts of Chinese date and 9 parts of cowherb seed and comprises pills, powder, tablets, oral liquid preparations and capsules prepared by the conventional preparation process or a modern preparation process. By mixing the raw material medicaments, the preparation has the effects of eliminating cold to stop pain, dispersing the depressed liver-energy, promoting blood circulation by removing blood stasis, regulating the menstrual function and relieving pain. By being taken orally, the preparation enhances the immune function of an organism, has good curative effects on the dysmenorrhea and the postpartum blood stasis which are caused by various etiological factors and is convenient to take. Clinical application indicates that the preparation has the advantages of quick function, remarkable curative effect, high tolerance, low cost and no toxic or side effect.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation for the treatment of dysmenorrhea, postnatal blood stasis.
Background technology
Dysmenorrhea is meant before and after menstrual period or between menstrual period, the hypogastric region spasmic pain occurs, and general malaise is arranged, and the person that has a strong impact on the daily life divides two kinds of constitutional and Secondary cases.The traditional Chinese medical science thinks that the reason that causes dysmenorrhea is that qi depression to blood stasis, cold and stagnate, dampness and heat stasis, deficient qi and blood, Liver and kidney refer to thanks to etc. that therefore, the treatment by Chinese herbs dysmenorrhea is based on the kidney invigorating, spleen invigorating, soothing the liver, QI and blood regulating.In the prior art, the prescription of treatment dysmenorrhea is more, and its curative effect differs, and is difficult in clinical application.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine preparation with dispersing cold for relieving pain, depressed liver-energy dispersing and QI regulating, blood circulation promoting and blood stasis dispelling, menstruction regulating and pain relieving effect, the dysmenorrhea, the postnatal blood stasis that cause at the various causes of disease all have good efficacy, and taking convenience, without any side effects.
The present invention has adopted following technical scheme:
Crude drug and the composition by weight thereof chosen are respectively: 15 parts of Herba Leonuris, 15 parts of Radix Angelicae Sinensis, 10 parts of Rhizoma Cyperis, 10 parts in Fructus Jujubae, 9 parts of Semen Vaccariae, its preparation comprise pill, powder, tablet, oral liquid formulations, the capsule preparations that utilization conventional formulation technology or modern preparation process are made.
The crude drug that the present invention chooses is pure Chinese crude drug, Herba Leonuri: blood circulation promoting and blood stasis dispelling, inducing diuresis to remove edema, heat-clearing and toxic substances removing.Radix Angelicae Sinensis: enrich blood and invigorate blood circulation, menstruction regulating and pain relieving, loosening bowel to relieve constipation.Rhizoma Cyperi: depressed liver-energy dispersing and QI regulating, menstruction regulating and pain relieving.Fructus Jujubae: invigorating the spleen and replenishing QI, nourishing blood to tranquillize the mind relaxes the property of medicine.Semen Vaccariae: promoting blood circulation to restore menstrual flow, stimulating milk secretion detumescence, inducing diuresis for treating stranguria syndrome.
Selected medical material gathers the effect of dispersing cold for relieving pain, depressed liver-energy dispersing and QI regulating, blood circulation promoting and blood stasis dispelling, menstruction regulating and pain relieving altogether.Improved human body immune function by for oral administration, the dysmenorrhea, the postnatal blood stasis that cause at the various causes of disease all have good efficacy, and taking convenience.Find through clinical practice, the present invention have effect rapidly, therapeutic effect obviously, better tolerance, advantage with low cost, without any side effects.
Use clinical patient's 376 examples of accepting for medical treatment of the present invention, the rehabilitation case is 352 examples.The rehabilitation standard is: menstrual cycle is normal, does not have uncomfortable symptom.
Concrete case: 1, Mrs Liu, 32 years old.People from Gongyi City.Postpartum hemorrhage amount is many; Main suit's menstruation reduces gradually.Breathe hard with having a dizzy spell, having palpitation, mental weariness is off one's feed.With this bright described pill, serve on 21 after, pain disappears, and recovers the antenatal cycle; Have no adverse reaction.Transference cure.
2, Mrs Xie, 23 years old.People from Xinmi City.Main suit's dysmenorrhea, the few color of amount are light, dim complexion, dry mouth and tougue, companion have a dizzy spell soreness of the waist and knees, weak pulse.Serve on for 4 weeks with capsule preparations of the present invention, pain disappears, observed 6 months, menstrual cycle be 28 days at every turn.
The specific embodiment
The Chinese medicine preparation of treatment dysmenorrhea of the present invention, postnatal blood stasis, crude drug and the composition by weight thereof chosen are respectively: 15 parts of Herba Leonuris, 15 parts of Radix Angelicae Sinensis, 10 parts of Rhizoma Cyperis, 10 parts in Fructus Jujubae, 9 parts of Semen Vaccariae; Its preparation comprises pill, powder, tablet, oral liquid formulations, the capsule preparations that utilization conventional formulation technology or modern preparation process are made.
Claims (1)
1. Chinese medicine preparation for the treatment of dysmenorrhea, postnatal blood stasis, it is characterized in that: crude drug and the composition by weight thereof chosen are respectively: 15 parts of Herba Leonuris, 15 parts of Radix Angelicae Sinensis, 10 parts of Rhizoma Cyperis, 10 parts in Fructus Jujubae, 9 parts of Semen Vaccariae, its preparation comprise pill, powder, tablet, oral liquid formulations, the capsule preparations that utilization conventional formulation technology or modern preparation process are made.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009101695153A CN102018847A (en) | 2009-09-09 | 2009-09-09 | Chinese medicinal preparation for treating dysmenorrhea and postpartum blood stasis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009101695153A CN102018847A (en) | 2009-09-09 | 2009-09-09 | Chinese medicinal preparation for treating dysmenorrhea and postpartum blood stasis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102018847A true CN102018847A (en) | 2011-04-20 |
Family
ID=43860896
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009101695153A Pending CN102018847A (en) | 2009-09-09 | 2009-09-09 | Chinese medicinal preparation for treating dysmenorrhea and postpartum blood stasis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102018847A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104415152A (en) * | 2013-09-09 | 2015-03-18 | 廖国建 | Medicament for treating uterine fibroids |
CN108478771A (en) * | 2018-06-12 | 2018-09-04 | 李传成 | A kind of Chinese medicine composition for treating the accumulation of capillary rupture clot |
CN108969737A (en) * | 2018-07-20 | 2018-12-11 | 周昌敏 | A kind of abdomen moxibustion composition and preparation method thereof for treating postpartum abdominal pain and dysmenorrhea |
-
2009
- 2009-09-09 CN CN2009101695153A patent/CN102018847A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104415152A (en) * | 2013-09-09 | 2015-03-18 | 廖国建 | Medicament for treating uterine fibroids |
CN108478771A (en) * | 2018-06-12 | 2018-09-04 | 李传成 | A kind of Chinese medicine composition for treating the accumulation of capillary rupture clot |
CN108969737A (en) * | 2018-07-20 | 2018-12-11 | 周昌敏 | A kind of abdomen moxibustion composition and preparation method thereof for treating postpartum abdominal pain and dysmenorrhea |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102423366A (en) | Chinese medicinal composition for treating metrorrhagia and metrostaxis | |
CN107715067B (en) | Pharmaceutical composition for conditioning blood stasis constitution and preparation method and application thereof | |
CN102188583A (en) | Traditional Chinese medicine for treating infertility | |
CN102370726A (en) | Compound Chinese medicinal preparation for treating chloasma and preparation method thereof | |
CN101843694B (en) | Chinese medicament for treating chronic hepatitis | |
CN102018847A (en) | Chinese medicinal preparation for treating dysmenorrhea and postpartum blood stasis | |
CN101502609B (en) | Chinese medicament preparation for cooling blood and dissolving stasis | |
CN101991738A (en) | Traditional Chinese medicine preparation for treating dysmenorrhea | |
CN101991794A (en) | Chinese traditional medicine preparation for treating eczema | |
CN101991812A (en) | Traditional Chinese medicine preparation for treating amenorrhea | |
CN102038926A (en) | Traditional Chinese medicine preparation for treating dysmenorrhea | |
CN101129718B (en) | Traditional Chinese medicine preparation for treating leuoderma | |
CN104127513A (en) | Medicine for treating localized scleroderma | |
CN101884747B (en) | Traditional Chinese medicine for treating chronic nephritis | |
CN102430026A (en) | Medicine for removing macula | |
CN101390985B (en) | Traditional Chinese medicine for treating diabetes acral necrosis | |
CN101843705B (en) | Chinese medicament for treating lupus erythematosus | |
CN101810742A (en) | Chinese medicament preparation for treating hypomenorrhea | |
CN101843707B (en) | Chinese medicament for treating chronic hepatitis | |
CN102018811A (en) | Chinese materia medica preparation for treating urticaria | |
CN102018765A (en) | Traditional Chinese medicine for treating diabetic acromelic gangrene | |
CN104288643A (en) | Pharmaceutical composition for treating consumptive disease nocturnal emission and preparation method thereof | |
CN101843879B (en) | Chinese medicament for treating liver cirrhosis | |
CN102266523A (en) | Traditional Chinese medicine for treating gestational dry stool | |
CN100364577C (en) | A medicine for treating gynecological disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110420 |